Drug intelligence / Profile preview

Buyuan Decoction

Development stage: Unknown
Lead developer: National Heritage and Innovation Center Construction Project
Administration: Oral

Overview

Buyuan Decoction is a traditional Chinese medicine (TCM) formula currently undergoing investigation in a large-sample, multicenter, randomized controlled study. It is being evaluated for its clinical efficacy in the treatment of chronic obstructive pulmonary disease (COPD) in its stable stage, specifically when combined with heat-sensitive moxibustion. The precise composition and detailed mechanism of action of this particular formulation for COPD are not explicitly detailed in the provided context or readily available in general search results under this exact name for this indication.

Other names: 补元汤

Beyond the preview

Go deeper on Buyuan Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Buyuan Decoction.

Explore the full profile